Itonic Holdings Ltd. (NASDAQ:ITOC) Stock Short Interest Falls 40.4%

Itonic Holdings Ltd. (NASDAQ:ITOC) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 62,815 shares, a decrease of 40.4% from the August 31st total of 105,460 shares. Based on an average daily volume of 117,111 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.4% of the company’s stock are short sold.

Itonic Price Performance

ITOC opened at $0.27 on Wednesday. The stock has a fifty day moving average of $0.29 and a 200-day moving average of $0.31. Itonic has a fifty-two week low of $0.22 and a fifty-two week high of $1.15.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded shares of Itonic from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, September 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

Itonic Company Profile

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.